A detailed history of Balyasny Asset Management LLC transactions in Absci Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 33,977 shares of ABSI stock, worth $91,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,977
Holding current value
$91,058
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.97 - $4.49 $100,911 - $152,556
33,977 New
33,977 $129,000
Q4 2023

Feb 14, 2024

BUY
$1.15 - $4.79 $50,365 - $209,782
43,796 New
43,796 $183,000
Q2 2023

Aug 14, 2023

BUY
$1.17 - $2.03 $508,411 - $882,116
434,540 New
434,540 $660,000
Q4 2022

Feb 14, 2023

BUY
$2.0 - $3.58 $27,042 - $48,405
13,521 Added 35.61%
51,490 $108,000
Q3 2022

Nov 14, 2022

BUY
$2.95 - $4.83 $41,409 - $67,798
14,037 Added 58.65%
37,969 $119,000
Q2 2022

Aug 15, 2022

BUY
$3.13 - $8.83 $74,907 - $211,319
23,932 New
23,932 $79,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $249M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.